Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
CARPA
Description:
An ambiguous term with no consistent meaning evident from the titles; it may be an acronym or a spelling variant in different contexts.
Related topics:
Complement system in diseases (17%),
Nanoparticle-Based Drug Delivery (15%)
OpenAlex ID:
keywords/carpa
Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity
2005
·
Janos Szebeni
·
Toxicology
·
640
PEGylated liposomes: immunological responses
2019
·
Marwa Mohamed
, Amr S. Abu Lila
, et al.
·
Science and Technology of Advanced Materials
·
558
PDF
Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention
2011
·
Janos Szebeni
, Franco Muggia
, et al.
·
Advanced Drug Delivery Reviews
·
446
PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective
2023
·
Rumiana Tenchov
, Janet M. Sasso
, et al.
·
Bioconjugate Chemistry
·
355
PDF
Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome
2011
·
János Szebeni
, Péter Bedőcs
, et al.
·
Nanomedicine Nanotechnology Biology and Medicine
·
227
Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction
2000
·
Janos Szebeni
, Lajos Baranyi
, et al.
·
American Journal of Physiology-Heart and Circulatory Physiology
·
175
Complement Activation-Related Pseudoallergy Caused by Liposomes, Micellar Carriers of Intravenous Drugs, and Radiocontrast Agents
2001
·
Janos Szebeni
·
Critical Reviews in Therapeutic Drug Carrier Systems
·
151
A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines
2012
·
János Szebeni
, Péter Bedőcs
, et al.
·
Advanced Drug Delivery Reviews
·
131
Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs
2015
·
Janos Szebeni
, Gert Storm
·
Biochemical and Biophysical Research Communications
·
111
A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor
2022
·
László Dézsi
, Tamás Mészáros
, et al.
·
GeroScience
·
62
PDF
Mechanism of nanoparticle-induced hypersensitivity in pigs: complement or not complement?
2018
·
János Szebeni
·
Drug Discovery Today
·
54
CARPA Standard Treatment Manual - A clinical manual for primary health care practitioners in remote and rural communities in Central and Northern Australia.
2004
·
Australian Prescriber
·
45
Complement activation in vitro and reactogenicity of low-molecular weight dextran-coated SPIONs in the pig CARPA model: Correlation with physicochemical features and clinical information
2017
·
Tamás Fülöp
, Réka Nemes
, et al.
·
Journal of Controlled Release
·
44
PDF
Analysis of Complement Activation by Nanoparticles
2017
·
Barry W. Neun
, Anna N. Ilinskaya
, et al.
·
Methods in molecular biology
·
44
Lessons learned from the porcine CARPA model: constant and variable responses to different nanomedicines and administration protocols
2015
·
Rudolf Urbanics
, Péter Bedőcs
, et al.
·
European Journal of Nanomedicine
·
43
Corpus Delecti: Performance Art of the Americas
2005
·
Coco Fusco
·
Routledge eBooks
·
42
High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment
2022
·
Johannes M. M. Boots
, Rogier A. M. Quax
·
Drug Safety
·
36
PDF
Unravelling the complexity of CARPA: a review of emerging advancements in therapeutic strategies
2025
·
Shubhi Saxena
, Subhi Sharma
, et al.
·
Archives of Dermatological Research
·
34
Involvement of complement activation in the pulmonary vasoactivity of polystyrene nanoparticles in pigs: unique surface properties underlying alternative pathway activation and instant opsonization
2018
·
Tamás Mészáros
, Gergely Kozma
, et al.
·
International Journal of Nanomedicine
·
33
PDF
COVID‐19 vaccine anaphylaxis: IgE, complement or what else? A reply to: “COVID‐19 vaccine anaphylaxis: PEG or not?”
2021
·
Beatriz Cabanillas
, Cezmi A. Akdis
, et al.
·
Allergy
·
30
PDF
Factor H inhibits complement activation induced by liposomal and micellar drugs and the therapeutic antibody rituximab in vitro
2015
·
Tamás Mészáros
, Ádám I. Csincsi
, et al.
·
Nanomedicine Nanotechnology Biology and Medicine
·
29
Acute physiological changes caused by complement activators and amphotericin B-containing liposomes in mice
2019
·
Erik Őrfi
, Tamás Mészáros
, et al.
·
International Journal of Nanomedicine
·
27
PDF
Pulmonary intravascular macrophages: prime suspects as cellular mediators of porcine CARPA
2015
·
Domokos Csukás
, Rudolf Urbanics
, et al.
·
European Journal of Nanomedicine
·
26
Complement Activation-Related Pathophysiological Changes in Anesthetized Rats: Activator-Dependent Variations of Symptoms and Mediators of Pseudoallergy
2019
·
László Dézsi
, Tamás Mészáros
, et al.
·
Molecules
·
23
PDF
Protein is expressed in all major organs after intravenous infusion of mRNA-lipid nanoparticles in swine
2024
·
Francesca Ferraresso
, Katherine Badior
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
20
Show more works
View as search
Works count:
134
Citation count:
3,578
Year
Topic
Type